| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.
|
Lancet
|
2007
|
15.92
|
|
2
|
Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer.
|
J Clin Oncol
|
2008
|
9.98
|
|
3
|
Capecitabine as adjuvant treatment for stage III colon cancer.
|
N Engl J Med
|
2005
|
6.22
|
|
4
|
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.
|
J Clin Oncol
|
2007
|
5.31
|
|
5
|
Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.
|
Lancet Oncol
|
2011
|
2.57
|
|
6
|
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial.
|
Int J Cancer
|
2010
|
2.43
|
|
7
|
AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney: a randomized, double-blind, placebo-controlled, phase 2 study.
|
Cancer
|
2012
|
1.17
|
|
8
|
Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer.
|
J Clin Oncol
|
2006
|
1.06
|
|
9
|
Phase II study of vinorelbine (alternating intravenous and oral) in combination with docetaxel as first-line chemotherapy in metastatic breast cancer.
|
Cancer Chemother Pharmacol
|
2008
|
0.77
|
|
10
|
[Small-cell lung cancer diagnostic and therapeutic recommendations of Polish Lung Cancer Group].
|
Pneumonol Alergol Pol
|
2007
|
0.75
|